FDA Inspection
Kendrick LaboratoriesKendrick Laboratories – FDA Inspection, Mar 10, 2020
Record Details
This FDA Inspection record concerns Kendrick Laboratories, with an inspection on March 10, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Kendrick Laboratories
- Inspection Date
- March 10, 2020
- Product Type
- Drugs
View Company Profile
ID · c4a41612-e1c3-4a7f-9255-4048eeec06c1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1120774
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.160(b)Scientifically sound laboratory controls
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Kendrick Laboratories
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 19, 2025 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 19, 2017 | Not classified | Minneapolis District Office | |
| June 30, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 26, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 4, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Kendrick Laboratories
- FDA Inspection 1283244 - 2025-09-19
- FDA Inspection 1038115 - 2017-12-19
- FDA Inspection 932435 - 2015-06-30
- FDA Inspection 808201 - 2012-11-26
- FDA Inspection 709029 - 2011-02-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.